Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jon Root
AddedMar 31, 2024
UpdatedMay 31, 2026
Jon Root

Jon Root

Board Member, Articulinx

Crunchbase

Jon Root's Career

Articulinx
Articulinx

Cupertino, CA, US

Board Member· Board
Okami Medical
Okami Medical

Aliso Viejo, CA, US

Board Member· Board
HealthJoy
HealthJoy

Chicago, IL, US

Board Member· Board
Ribon Therapeutics
Ribon Therapeutics

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jon Root's Career

Articulinx
Articulinx
Seed$12.2M302007Cupertino, CA, US
Board Member· Board

Leadership at Articulinx

Dr David WhiteDr David WhiteBoard Member
Michael HogendijkMichael HogendijkFounder
Michael J OrthMichael J OrthCEO

Similar to Articulinx

Articulate BiosciencesArticulate BiosciencesLowell, MA, USMedical Devicesest. 2016Articulate BiosciencesLowell, MA, US · est. 2016

Articulate Biosciences, a Boston University spin-off, develops gels to treat arthritis and soft tissue diseases.

Angel · $224.9k5
SpinalMotionSpinalMotionMountain View, CA, USMedical Devicesest. 2004SpinalMotionMountain View, CA, US · est. 2004

SpinalMotion, Inc.: US-based manufacturer of medical devices, specializing in artificial disc implants.

Series D · $60.2M30
Artio MedicalArtio MedicalOlathe, KS, USMedical Devicesest. 2011Artio MedicalOlathe, KS, US · est. 2011

Artio Medical, Inc.: Innovating endovascular devices for vascular, neurovascular, and heart diseases in the US.

Series A · $73.4M29
Core Essence OrthopaedicsCore Essence OrthopaedicsFort Washington, PA, USMedical Devicesest. 2007Core Essence OrthopaedicsFort Washington, PA, US · est. 2007

Core Essence Orthopaedics: US-based manufacturer of minimally invasive orthopedic devices.

Angel · $18.4M7
Okami Medical
Okami Medical
Series D$14.7M122014Aliso Viejo, CA, US
Board Member· Board

Leadership at Okami Medical

Paul LubockPaul LubockCo-Founder
Brian CoxBrian CoxCo-Founder
Rhonda RobbRhonda RobbCEO
Bob RosenbluthBob RosenbluthCo-Founder
HealthJoy
HealthJoy
Series D$108.5M3822014Chicago, IL, US
Board Member· Board

Leadership at HealthJoy

Brandon CruzBrandon CruzBoard Member
Doug Morse-SchindlerDoug Morse-SchindlerCo-Founder
Saurabh BhansaliSaurabh BhansaliBoard Member
Justin HollandJustin HollandCo-Founder
Ribon Therapeutics
Ribon Therapeutics
Series B$259M572015Cambridge, MA, US
Board Member· Board

Leadership at Ribon Therapeutics

Jeff GoaterJeff GoaterBoard Member
Peter SvennilsonPeter SvennilsonBoard Member
Jodie MorrisonJodie MorrisonBoard Member
Paul ChangPaul ChangCo-Founder
Jim AudiaJim AudiaBoard Member
Tim MitchisonTim MitchisonCo-Founder

Similar to Ribon Therapeutics

RibonovaRibonovaWynnewood, PA, USPharmaceuticalsest. 2011RibonovaWynnewood, PA, US · est. 2011

US-based Ribonova Inc, founded in 2011, specializes in manufacturing pharmaceuticals for human and veterinary use.

Angel · $25k5
RibometrixRibometrixGreenville, NC, USDrug Discoveryest. 2014RibometrixGreenville, NC, US · est. 2014

Ribometrix, a US-based biotech firm, leverages 3D RNA analysis for novel drug discovery.

Series A · $45.3M29
ENB TherapeuticsENB TherapeuticsNew York City, NY, USCancer Therapeuticsest. 2015ENB TherapeuticsNew York City, NY, US · est. 2015

ENB Therapeutics, Inc.: A US-based biopharmaceutical firm developing novel inhibitors to treat cancers.

Series A · $8.2M8
Redona TherapeuticsRedona TherapeuticsWatertown, MA, USCancer Treatmentest. 2016Redona TherapeuticsWatertown, MA, US · est. 2016

Redona Therapeutics: Advancing small molecule therapies for cancer via ncRNA modulation.

Series A · $66.8M24

Jon Root's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Jon Root

Gregory FreitagGregory FreitagBoard Member · AxogenJonathan RootJonathan RootBoard Member · Inari MedicalHarrison BainsHarrison BainsBoard Member · BG MedicineJay SkylerJay SkylerBoard Member · Intarcia TherapeuticsStephen BrusoStephen BrusoBoard Member · Vesigen TherapeuticsJeff HargrovesJeff HargrovesBoard Member · Riverside Partners